Effect of hemoperfusion using polymyxin B-immobilized fibers on acute lung injury in a rat sepsis model

International Journal of Medical Sciences

Volumn 11, Issue 3, 2014, Pages 255-261

  Iba, Toshiaki ^a   Nagaoka, Isao ^a   Yamada, Atsushi ^a   Nagayama, Masataka ^a   Miki, Takahiro ^a  

^a JUNTENDO UNIVERSITY   (Japan)

Author keywords

Acute lung injury; Hemoadsorption; Intravital microscope; Lipopolysaccharide; Polymyxin B immobilized fibers

Indexed keywords

LIPOPOLYSACCHARIDE; POLYMYXIN B; ANTIINFECTIVE AGENT;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ERYTHROCYTE; EXTRACORPOREAL CIRCULATION; HEMOPERFUSION; IMMOBILIZATION; LEUKOCYTE ADHERENCE; LEUKOCYTE COUNT; LUNG CIRCULATION; LUNG EDEMA; NONHUMAN; OXYGEN TENSION; RAT; SEPSIS; THROMBOCYTE ADHESION; THROMBOCYTE COUNT; VENULE; ANIMAL; CHEMICALLY INDUCED; CHEMISTRY; DISEASE MODEL; DRUG EFFECTS; HUMAN; LEUKOCYTE; MICROCIRCULATION; PATHOLOGY; PATHOPHYSIOLOGY;

ACUTE LUNG INJURY; ANIMALS; ANTI-BACTERIAL AGENTS; DISEASE MODELS, ANIMAL; ERYTHROCYTES; HEMOPERFUSION; HUMANS; LEUKOCYTES; LIPOPOLYSACCHARIDES; MICROCIRCULATION; PLATELET ADHESIVENESS; POLYMYXIN B; RATS; SEPSIS;

EID: 84892576501     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.6276     Document Type: Article

References (28)

1. Shoji H, Tani T, Hanasawa K, et al. Extracorporeal endotoxin removal by polymyxin B immobilized fiber cartridge designing and antiendotoxin efficacy in the clinical application. Ther Apher. 1998; 2: 3-12.
2. Shimizu T, Hanasawa K, Sato K, et al. Direct hemoperfusion with polymyxin-B-immobilized fiber columns improves septic hypotension and reduces inflammatory mediators in septic patients with colorectal perforation. Langenbecks Arch Surg. 2008; 394: 303-11.
3. Cruz DN, Antonelli M, Fumagalli R, et al. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA. 2009; 301: 2445-52.
4. Tachibana K, Inoue Y, Nishiyama A, et al. Polymyxin-B hemoperfusion for acute exacerbation of idiopathic pulmonary fibrosis: serum IL-7 as a prognostic marker. Sarcoidosis Vasc Diffuse Lung Dis. 2011; 28: 113-22.
5. Enomoto N, Suda T, Uto T, et al. Possible therapeutic effect of direct haemoperfusion with a polymyxin B immobilized fibre column (PMX-DHP) on pulmonary oxygenation in acute exacerbations of interstitial pneumonia. Respirology. 2008; 13: 452-60.
6. Hara S, Ishimoto H, Sakamoto N, et al: Direct hemoperfusion using immobilized polymyxin B in patients with rapidly progressive interstitial pneumonias: a retrospective study. Respiration. 2011; 81: 107-17.
7. Antonelli M, Fumagalli R, Cruz DN, et al. PMX endotoxin removal in the clinical practice: results from the EUPHAS trial. Contrib Nephrol. 2010; 167: 83-90.
8. Iba T, Kidokoro A, Fukunaga M, et al. Factor Xa-inhibitor (DX-9065a) modulates the leukocyte-endothelial cell interaction in endotoxemic rat. Shock. 2002; 17: 159-62.
9. Cruz DN, Perazella PA, Bellomo R, et al. Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review. Crit Care. 2007; 11: R47-58.
10. Vincent JL, Laterre PF, Cohen J, et al. A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection. Shock. 2005; 23: 400-5.
11. Nakamura T, Fujiwara N, Sato E, et al. Effect of polymyxin B-immobilized fiber hemoperfusion on serum high mobility group box-1 protein levels and oxidative stress in patients with acute respiratory distress syndrome. ASAIO J. 2009; 55: 395-9.
12. Takahashi G, Hoshikawa K, Matsumoto N, et al. Changes in serum S100A12 and sRAGE associated with improvement of the PaO(2)/FiO(2) ratio following PMX-DHP therapy for postoperative septic shock. Eur Surg Res. 2011; 47: 135-40.
13. Weiner-Kronish JP, Gropper MA, Matthay MA. The adult respiratory distress syndrome: definition and prognosis, pathogenesis and treatment. Br J Anaesthesia. 1990; 65: 107-29.
14. Havemann K, Gramse G. Physiology and pathophysiology of neutral proteinases of human granulocytes. Adv Exp Med Biol. 1984; 84: 1-20.
15. Iba T, Kidokoro A, Fukunaga M, et al. Pretreatment of sivelestat sodium hydrate improves the lung microcirculation and alveolar damage in lipopolysaccharide-induced acute lung inflammation in hamsters. Shock. 2006; 26: 95-8.
16. Iba T, Okamoto K, Kawasaki S, et al. Effect of hemoperfusion using polymyxin B-immobilized fibers on non-shock rat sepsis model. J Surg Res. 2011; 171: 755-61.
17. Yoshida T, Kodama M, Tamura Y, et al. Direct hemoperfusion with a polymyxin B-immobilized fiber column eliminates neutrophils and improves pulmonary oxygenation--a comparison of two cases with acute exacerbation of idiopathic pulmonary fibrosis. J Jpn Resp Soc. 2007; 45: 890-7.
18. Abe S, Seo Y, Hayashi H, et al. Neutrophil adsorption by polymyxin B-immobilized fiber column for acute exacerbation in patients with interstitial pneumonia: a pilot study. Blood Purif. 2010; 29: 321-6.
19. Kumagai T, Takeyama N, Yabuki T, et al. Apheresis of activated leukocytes with an immobilized polymyxin B filter in patients with septic shock. Shock. 2010; 34: 461-6.
20. Tsushima K, Koizumi T, Yoshikawa S, et al. Polymyxin B immobilized column is effective for hydrochloric acid-induced lung injury in rats. Eur J Pharmacol. 2006; 535: 270-9.
21. Kushi H, Miki T, Nakahara J, et al. Hemoperfusion with an immobilized polymyxin B column reduces the blood level of neutrophil elastase. Blood Purif. 2006; 24: 212-7.
22. Naka T, Shinozaki M, Akizawa T, et al. The effect of continuous veno-venous hemofiltration or direct hemoperfusion with polymyxin B-immobilized fiber on neutrophil respiratory oxidative burst in patients with sepsis and septic shock. Ther Apher Dial. 2006; 10: 7-11.
23. Ikeda T. Hemoadsorption in critical care. Ther Apher. 2002, 6:189-92.
24. Fitzgerald JR, Foster TJ, Cox D. The interaction of bacterial pathogens with platelets. Nat Rev Microbiol. 2006; 4: 445-57.
25. Blair P, Rex S, Vitseva O, et al. Stimulation of Toll-like receptor 2 in human platelets induces a thromboinflammatory response through activation of phosphoinositide 3-kinase. Circ Res. 2009; 104: 346-54.
26. Clark SR, Ma AC, Tavener SA, et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med. 2007; 13: 463-9.
27. Iba T, Gando S, Murata A, et al. Predicting the severity of systemic inflammatory response syndrome (SIRS)-associated coagulopathy with hemostatic molecular markers and vascular endothelial injury markers. J Trauma. 2007; 63:1093-8.
28. Kase Y, Obata T, Okamoto Y, et al. Removal of 2-AG by direct hemoperfusion therapy with polymyxin B immobilized fibers benefits patients with septic shock. Ther Apher Dial. 2008; 12: 374-80.